BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
read more
Ainslie Little, PH.D. — SVP, Corporate Strategy at BlueRock Therapeutics
Executive Bio
Ainslie Little, PhD, leads BlueRock’s strategy functions, including Business Development, Portfolio Strategy, New Product Planning, and Alliance Management. Ainslie joined BlueRock in 2017 to build BlueRock’s Intellectual Property portfolio and has since served as a leading member of business deals, partnerships and strategic initiatives. Previously, Ainslie practiced at leading law firms in the United States and Canada with a focus on patent drafting, prosecution and strategy. Ainslie contributed to protecting some of the foundational IP in cell therapy, including iPSC reprogramming, PSC manufacturing, and generation of authentic neural, cardiac and immune cells.
Executive Team Culture Ratings from BlueRock Therapeutics Employees
TOP
5%
BlueRock Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
BlueRock Therapeutics' Executive Team at a Glance
Based on 357 ratings, BlueRock Therapeutics' employees are very satisfied with their Executive Team and give them an “A+” or 92/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the HR department thinks more highly of the Executive Team relative to the Business Development department.
BlueRock Therapeutics' Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 201-500 Employees.
×